胃经口内镜下幽门肌切开术治疗难治性胃轻瘫:早期结局的系统评价与汇总分析
该系统评价汇总了10项研究共292例难治性胃轻瘫患者,评估胃经口内镜下幽门肌切开术(G-POEM)的疗效与安全性。结果显示83.9%的操作后症状显著改善,总体不良事件率为6.8%,短期安全性和有效性较好。
要点
- G-POEM在难治性胃轻瘫患者中技术可行,症状改善率83.9%。
- 总体不良事件率6.8%,短期安全性可接受。
- 术后2小时和4小时胃排空残余百分比显著下降。
核心结论
- G-POEM在短期内对难治性胃轻瘫显示出有前景的安全性和有效性。
研究设计与样本
- 系统评价与汇总分析,检索Medline、Scopus、EMBASE至2019年1月,纳入10项研究共292例患者,其中2项为前瞻性研究。
主要发现
- 内镜下幽门肌切开术在所有患者中均可行。
- 83.9%的操作后症状显著改善,平均随访7.8±5.5个月。
- 术后2小时和4小时胃排空残余百分比显著下降。
- 总体不良事件率为6.8%。
临床怎么用
- 对于难治性胃轻瘫患者,G-POEM可作为短期改善症状的微创选择。
局限性
- 纳入研究仅2项为前瞻性,多数为回顾性设计,证据等级有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Gastroparesis (GP) is a chronic debilitating condition. Prior pyloric-targeted procedures are either invasive or have questionable efficacy. Gastric peroral pyloromyotomy (G-POEM) has been proposed as a minimally invasive approach. We performed a pooled analysis to evaluate the efficacy and safety of G-POEM for GP. METHODS: Electronic databases (Medline, Scopus, EMBASE) were searched up to January 2019. Studies including patients who underwent G-POEM for GP were eligible. Procedural, clinical, and safety outcomes were assessed by pooling data with a random- or fixed-effect model according to the degree of heterogeneity to obtain a proportion with a 95% confidence interval. RESULTS: Ten studies were eligible for inclusion (292 patients), and 2 of the 10 studies were prospective. Seven studies were performed in the United States, 2 in France, and 1 in China. Endoscopic pyloromyotomy was feasible in all patients. Significant symptomatic improvement was achieved after 83.9% of procedures (mean follow-up, 7.8 ± 5.5 months). When comparing the mean values of pre- and postprocedural scintigraphic evolution, there was a significant decrease of the residual percentage at 2 and 4 hours. The overall adverse events rate was 6.8%. CONCLUSIONS: G-POEM appears to be a promising approach for GP in terms of safety and efficacy outcomes in the short term.
引用
- Spadaccini M, Maselli R, Chandrasekar VT, et al. Gastric peroral endoscopic pyloromyotomy for refractory gastroparesis: a systematic review of early outcomes with pooled analysis. Gastrointest Endosc. 2019. PMID: 31809720. doi:10.1016/j.gie.2019.11.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。